Cargando…
Erratic enteric absorption of dolutegravir in a critically ill patient
Autores principales: | de Antonio-Cuscó, Marta, Parrilla, Francisco José, Freud, Hernando Knobel, Echeverría-Esnal, Daniel, Font, Andrea Castellví, Vázquez, Antonia, Masclans, Joan Ramon, Ferrández, Olivia, Grau, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333120/ https://www.ncbi.nlm.nih.gov/pubmed/35644951 http://dx.doi.org/10.37201/req/004.2022 |
Ejemplares similares
-
SARS-CoV-2 could be spread through hospital medication dispensed to patients: A prospective observational study
por: Grau, Santiago, et al.
Publicado: (2021) -
Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic
por: Grau, Santiago, et al.
Publicado: (2021) -
Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
por: Carballo, Nuria, et al.
Publicado: (2022) -
HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report
por: van Kampen, Jeroen J.A., et al.
Publicado: (2022) -
Impact of Generic Entry on Hospital Antimicrobial Use: A Retrospective Quasi-Experimental Interrupted Time Series Analysis
por: Espona, Mercè, et al.
Publicado: (2021)